FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients
Articles > Article · 2016
Authors: Mehmet Nuri Turan, Fatih Kırcellı, Mustafa Yaprak, Ali Riza Sisman, Ozkan Gungor, Selen BAYRAKTAROĞLU, Mehmet ÖZKAHYA, Gülay AŞCI, Jurgen Floege, Ercan OK
International Urology and Nephrology, Journal Indexed in SCI Expanded, International, WoS, 2016, vol 48, pp 609-617
DOI: 10.1007/s11255-016-1231-1
Summary
High fibroblast growth factor-23 (FGF-23) levels are associated with mortality and cardiovascular events in patients with chronic kidney disease. The aim of this cross-sectional study was to investigate the relationship between plasma FGF-23 levels and coronary artery calcification and carotid artery intima-media thickness (CA-IMT) in hemodialysis (HD) patients.